Global Flow Cytometry In Oncology And Immunology Market Report 2024

Flow Cytometry In Oncology And Immunology Global Market Report 2024 – By Type (Immunology, Oncology), By Technology (Cell-Based Flow Cytometry, Bead-Based Flow Cytometry), By Application (Translational Research, Clinical Research), By End User (Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Flow Cytometry In Oncology And Immunology Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Flow Cytometry In Oncology And Immunology Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Flow Cytometry In Oncology And Immunology Market Definition

Flow cytometry in oncology and immunology refers to a technology and method used in oncology and immunology to analyze and characterize cells based on their physical and chemical properties.

The main types of flow cytometry in oncology and immunology are immunology and oncology. Immunology is a branch of biomedical science that studies the immune system and its response to foreign substances known as antigens. In oncology and immunology, flow cytometry includes different technologies, such as cell-based flow cytometry and bead-based flow cytometry, used in several applications, including translational research and clinical research, by end users such as hospitals, diagnostic laboratories, reference laboratories, pharmaceutical and biotechnology companies, academic research institutes, contract research organizations, and others.

Flow Cytometry In Oncology And Immunology Market Segmentation

The flow cytometry in oncology and immunology market covered in this report is segmented –

1) By Type: Immunology, Oncology

2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry

3) By Application: Translational Research, Clinical Research

4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Global Flow Cytometry In Oncology And Immunology Market Size 2023 to 2028: Graph

Flow Cytometry In Oncology And Immunology Market Size 2024 And Growth Rate

The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $1.89 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to advancements in cancer research, immunology research growth, diagnostic applications, rise in autoimmune diseases, drug development and clinical trials.

Flow Cytometry In Oncology And Immunology Market Growth Forecast

The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to integration with genomics and proteomics, growing adoption of single-cell analysis, expanding applications in infectious diseases, rise in cancer incidence, point-of-care flow cytometry. Major trends in the forecast period include immunophenotyping for immunotherapy, miniaturization of flow cytometry systems, multiparametric analysis, shift towards spectral flow cytometry, collaborative research initiatives.

Flow Cytometry In Oncology And Immunology Market Driver: Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth

The increasing prevalence of cancer is expected to propel the growth of flow cytometry in the oncology and immunology market going forward. Cancer is a disease to describe a group of disorders characterized by the uncontrolled growth and spread of abnormal cells in the body. Flow cytometry is a widely used technique in oncology and immunology for studying cancer and immune cells. For instance, in October 2022, in Macmillan Cancer Support, a UK-based healthcare charity organization, 3 million people had cancer in 2020, and it is estimated that it will rise to 3.5 million by 2025 and 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of flow cytometry in the oncology and immunology markets.

Flow Cytometry In Oncology And Immunology Market Driver: Surge In Hiv/Aids Cases Is Anticipated To Fuel The Flow Cytometry Market Growth

The rising prevalence of HIV/AIDS is expected to propel the growth of flow cytometry in the oncology and immunology market going forward. HIV is a virus that attacks the body's immune system, specifically CD4 cells, white blood cells crucial for fighting infections. Over time, untreated HIV can lead to the disease AIDS, which is the final stage of HIV infection. Flow cytometry is a powerful technique used in HIV/AIDS research and clinical settings to analyze and characterize cells, particularly immune cells, based on their physical and chemical properties. Flow cytometry can be used to identify latently infected T cells harboring the HIV genome but not actively producing the virus. For instance, in July 2023, according to the World Health Organization, a Switzerland-based Intergovernmental organization, in the year 2022, there were approximately 39.0 million individuals living with HIV, with an estimated range of 33.1 to 45.7 million. Additionally, about 630,000 people died due to HIV-related causes during the same period, with a confidence interval of 480,000 to 880,000. Furthermore, around 1.3 million people contracted HIV in 2022, with a range of 1.0 to 1.7 million. Therefore, the rising prevalence of HIV/AIDS is driving the flow cytometry in the oncology and immunology market.

Global Flow Cytometry In Oncology And Immunology Market Major Players

Major companies operating in the flow cytometry in oncology and immunology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason.

Global Flow Cytometry In Oncology And Immunology Market Trend: Technological Innovations Propel Flow Cytometry In Oncology And Immunology

Technological advancements are a key trend gaining popularity in flow cytometry in the oncology and immunology market. Major companies operating in flow cytometry in the oncology and immunology markets are adopting new technologies to sustain their position in the market. For instance, in September 2022, Becton Dickinson, and Company, a US-based medical technology provider, launched BD Research Cloud for flow cytometry in oncology and immunology. BD Cloud is a cloud-based software system that simplifies the flow cytometry process for researchers working in various fields, such as immunology, virology, infectious disease, and oncology surveillance, to enable higher-quality studies with quicker time to insight. BD is leveraging innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly introduced BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, to enhance the capabilities of flow cytometry, enabling researchers to optimize and advance their groundbreaking studies. Built on an industry-standard cloud infrastructure, BD Research Cloud is uniquely suited for BD equipment and reagents.

Global Flow Cytometry In Oncology And Immunology Market Trend: Product Innovations With Automated Sample Preparation In Flow Cytometry

Major companies operating in flow cytometry in the oncology and immunology market are focusing on developing innovative solutions such as automated sample preparation systems. An automated sample preparation system refers to a specialized laboratory instrument designed to streamline and automate the various steps involved in sample preparation for analysis. For instance, in March 2022, Beckman Coulter Life Sciences, a US-based life science company announced the launch of ‘CellMek SPS’. It is fully automated sample preparation system designed for clinical flow cytometry. It provides on-demand processing for a variety of sample types, assisting laboratories in extending their capabilities. The CellMek SPS, building on a robust history of lab automation, integrates features that enhance efficiency by automating outdated manual preparation methods. This innovative system ensures a seamless workflow, delivering a continuous output of samples ready for analysis with complete traceability.

Flow Cytometry In Oncology And Immunology Market Merger And Acquisition: Diasorin's Expansion Through The Luminex Corporation Acquisition

In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for $1.8 billion. Through the acquisition, DiaSorin S.p.A. will enhance its current portfolio across the life science sector, fostering access to academic and scientific research, growing collaboration with biopharma businesses, and enhancing access. Luminex Corporation is a US-based biotechnology company that provides flow cytometry in oncology and immunology.

Regional Outlook For The Global Flow Cytometry In Oncology And Immunology Market

North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the flow cytometry in oncology and immunology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The flow cytometry in oncology and immunology market includes revenues earned by entities by providing services such as cell-based assay services, drug development services, and minimal residual disease (MRD) monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The flow cytometry in oncology and immunology market also consists of sales of products flow cytometers, fluorescence-activated cell sorters (FACS), monoclonal antibodies, and fluorochromes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The flow cytometry in oncology and immunology research report is one of a series of new reports from The Business Research Company that provides flow cytometry in oncology and immunology market statistics, including the flow cytometry in oncology and immunology industry's global market size, regional shares, competitors with flow cytometry in oncology and immunology market share, detailed flow cytometry in oncology and immunology market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry in oncology and immunology industry. This flow cytometry in oncology and immunology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Flow Cytometry In Oncology And Immunology Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $2.1 billion
Revenue Forecast In 2033 $3.07 billion
Growth Rate CAGR of 10% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton Dickinson and Company; Laboratory Corporation of America Holdings; Agilent Technologies Inc.; Sartorius AG; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Sysmex Partec GmbH; OPKO Health Inc.; Miltenyi Biotec; NeoGenomics Laboratories Inc.; Luminex Corporation; Q2 Solutions LLC; Enzi Biochem Inc.; DiaSorin S.p.A;BioLegend Inc.; Cytek Biosciences Inc.; Cell Signaling Technology Inc.; Standard BioTools Inc.; Sony Biotechnology Inc.; NanoCellect Biomedical Inc.; Nexcelom Bioscience LLC; CytoReason.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Flow Cytometry In Oncology And Immunology Market Characteristics

    3. Flow Cytometry In Oncology And Immunology Market Trends And Strategies

    4. Flow Cytometry In Oncology And Immunology Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Flow Cytometry In Oncology And Immunology Market Size and Growth

    5.1. Global Flow Cytometry In Oncology And Immunology Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Flow Cytometry In Oncology And Immunology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Flow Cytometry In Oncology And Immunology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Flow Cytometry In Oncology And Immunology Market Segmentation

    6.1. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Immunology

    Oncology

    6.2. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cell-Based Flow Cytometry

    Bead-Based Flow Cytometry

    6.3. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Translational Research

    Clinical Research

    6.4. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Diagnostic Laboratories

    Reference Laboratories

    Pharmaceutical And Biotechnology Companies

    Academic Research Institutes

    Contract Research Organizations

    Other End Users

    7. Flow Cytometry In Oncology And Immunology Market Regional And Country Analysis

    7.1. Global Flow Cytometry In Oncology And Immunology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Flow Cytometry In Oncology And Immunology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Flow Cytometry In Oncology And Immunology Market

    8.1. Asia-Pacific Flow Cytometry In Oncology And Immunology Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Flow Cytometry In Oncology And Immunology Market

    9.1. China Flow Cytometry In Oncology And Immunology Market Overview

    9.2. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Flow Cytometry In Oncology And Immunology Market

    10.1. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Flow Cytometry In Oncology And Immunology Market

    11.1. Japan Flow Cytometry In Oncology And Immunology Market Overview

    11.2. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Flow Cytometry In Oncology And Immunology Market

    12.1. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Flow Cytometry In Oncology And Immunology Market

    13.1. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Flow Cytometry In Oncology And Immunology Market

    14.1. South Korea Flow Cytometry In Oncology And Immunology Market Overview

    14.2. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Flow Cytometry In Oncology And Immunology Market

    15.1. Western Europe Flow Cytometry In Oncology And Immunology Market Overview

    15.2. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Flow Cytometry In Oncology And Immunology Market

    16.1. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Flow Cytometry In Oncology And Immunology Market

    17.1. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Flow Cytometry In Oncology And Immunology Market

    18.5. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Flow Cytometry In Oncology And Immunology Market

    19.9. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Flow Cytometry In Oncology And Immunology Market

    20.13. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Flow Cytometry In Oncology And Immunology Market

    21.1. Eastern Europe Flow Cytometry In Oncology And Immunology Market Overview

    21.2. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Flow Cytometry In Oncology And Immunology Market

    22.1. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Flow Cytometry In Oncology And Immunology Market

    23.1. North America Flow Cytometry In Oncology And Immunology Market Overview

    23.2. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Flow Cytometry In Oncology And Immunology Market

    24.1. USA Flow Cytometry In Oncology And Immunology Market Overview

    24.2. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Flow Cytometry In Oncology And Immunology Market

    25.1. Canada Flow Cytometry In Oncology And Immunology Market Overview

    25.2. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Flow Cytometry In Oncology And Immunology Market

    26.1. South America Flow Cytometry In Oncology And Immunology Market Overview

    26.2. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Flow Cytometry In Oncology And Immunology Market

    27.1. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Flow Cytometry In Oncology And Immunology Market

    28.1. Middle East Flow Cytometry In Oncology And Immunology Market Overview

    28.2. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Flow Cytometry In Oncology And Immunology Market

    29.1. Africa Flow Cytometry In Oncology And Immunology Market Overview

    29.2. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Flow Cytometry In Oncology And Immunology Market Competitive Landscape And Company Profiles

    30.1. Flow Cytometry In Oncology And Immunology Market Competitive Landscape

    30.2. Flow Cytometry In Oncology And Immunology Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Danaher Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck KGaA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Becton Dickinson and Company

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Laboratory Corporation of America Holdings

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Flow Cytometry In Oncology And Immunology Market Other Major And Innovative Companies

    31.1. Agilent Technologies Inc.

    31.2. Sartorius AG

    31.3. Beckman Coulter Inc.

    31.4. Bio-Rad Laboratories Inc.

    31.5. Sysmex Partec GmbH

    31.6. OPKO Health Inc.

    31.7. Miltenyi Biotec

    31.8. NeoGenomics Laboratories Inc.

    31.9. Luminex Corporation

    31.10. Q2 Solutions LLC

    31.11. Enzi Biochem Inc.

    31.12. DiaSorin S.p.A

    31.13. BioLegend Inc.

    31.14. Cytek Biosciences Inc.

    31.15. Cell Signaling Technology Inc.

    32. Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking

    33. Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market

    35. Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis

    35.1 Flow Cytometry In Oncology And Immunology Market In 2028 - Countries Offering Most New Opportunities

    35.2 Flow Cytometry In Oncology And Immunology Market In 2028 - Segments Offering Most New Opportunities

    35.3 Flow Cytometry In Oncology And Immunology Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Flow Cytometry In Oncology And Immunology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Flow Cytometry In Oncology And Immunology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Danaher Corporation Financial Performance
  • Table 77: Merck KGaA Financial Performance
  • Table 78: Becton Dickinson and Company Financial Performance
  • Table 79: Laboratory Corporation of America Holdings Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Flow Cytometry In Oncology And Immunology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Flow Cytometry In Oncology And Immunology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Danaher Corporation Financial Performance
  • Figure 77: Merck KGaA Financial Performance
  • Figure 78: Becton Dickinson and Company Financial Performance
  • Figure 79: Laboratory Corporation of America Holdings Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the flow cytometry in oncology and immunology market?

Flow cytometry in oncology and immunology refers to a technology and method used in oncology and immunology to analyze and characterize cells based on their physical and chemical properties. For further insights on the flow cytometry in oncology and immunology market, request a sample here

How will the flow cytometry in oncology and immunology market drivers and restraints affect the flow cytometry in oncology and immunology market dynamics? What forces will shape the flow cytometry in oncology and immunology industry going forward?

The flow cytometry in oncology and immunology market major growth driver - Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth. For further insights on the flow cytometry in oncology and immunol request a sample here

What is the forecast market size or the forecast market value of the flow cytometry in oncology and immunology market?

The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $1.89 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to advancements in cancer research, immunology research growth, diagnostic applications, rise in autoimmune diseases, drug development and clinical trials. The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to integration with genomics and proteomics, growing adoption of single-cell analysis, expanding applications in infectious diseases, rise in cancer incidence, point-of-care flow cytometry. Major trends in the forecast period include immunophenotyping for immunotherapy, miniaturization of flow cytometry systems, multiparametric analysis, shift towards spectral flow cytometry, collaborative research initiatives. For further insights on the flow cytometry in oncology and immunology market, request a sample here

How is the flow cytometry in oncology and immunology market segmented?

The flow cytometry in oncology and immunology market is segmented
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End UsersFor further insights on the flow cytometry in oncology and immunology market,
request a sample here

Which region has the largest share of the flow cytometry in oncology and immunology market? What are the other regions covered in the report?

North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the flow cytometry in oncology and immunology market, request a sample here.

Who are the major players in the flow cytometry in oncology and immunology market?

Major companies operating in the flow cytometry in oncology and immunology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason. For further insights on the flow cytometry in oncology and immunology market, request a sample here.

What are the key trends in the flow cytometry in oncology and immunology market?

Major trend in the flow cytometry in oncology and immunology market - Technological Innovations Propel Flow Cytometry In Oncology And Immunology. For further insights on the flow cytometry in oncology and immunology market, request a sample here.

What are the major opportunities in the flow cytometry in oncology and immunology market? What are the strategies for the flow cytometry in oncology and immunology market?

For detailed insights on the major opportunities and strategies in the flow cytometry in oncology and immunology market, request a sample here.

How does the flow cytometry in oncology and immunology market relate to the overall economy and other similar markets?

For detailed insights on flow cytometry in oncology and immunology market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the flow cytometry in oncology and immunology industry?

For detailed insights on the mergers and acquisitions in the flow cytometry in oncology and immunology industry, request a sample here.

What are the key dynamics influencing the flow cytometry in oncology and immunology market growth? SWOT analysis of the flow cytometry in oncology and immunology market.

For detailed insights on the key dynamics influencing the flow cytometry in oncology and immunology market growth and SWOT analysis of the flow cytometry in oncology and immunology industry, request a sample here.